Artivion Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Artivion Inc 公司

Artivion, Inc. 是一家醫療器械公司，從事製造、加工和分銷用於治療主動脈疾病、心臟瓣膜疾病、主動脈瘤和主動脈夾層患者的心臟和血管外科手術的醫療器械和可植入人體組織。該公司的部門包括醫療器械和保存服務。醫療器械部門包括主動脈支架移植物、手術密封劑和 On-X 的銷售。保存服務部門包括保存心臟和血管可植入人體組織的服務。該公司有四個產品系列：主動脈支架移植物、手術密封劑、On-X 機械心臟瓣膜和相關手術產品以及可植入心臟和血管人體組織。主動脈支架移植物包括主動脈弓支架移植物、腹部支架移植物和合成血管移植物。手術密封劑包括 BioGlue 手術粘合劑產品。該公司還銷售或分銷 PhotoFix 牛手術貼片。

Artivion Inc簡介



公司代碼AORT

公司名稱Artivion Inc

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

員工數量1600

證券類型Ordinary Share

年結日Feb 12

公司地址1655 Roberts Boulevard N W

城市KENNESAW

上市交易所NYSE Consolidated

國家United States of America

郵編30144

電話17704193355

網址https://artivion.com/

公司代碼AORT

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

Artivion Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

--

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

--

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer

121.36K

+10.09%

Mr. James W. Bullock

Independent Director

68.65K

+10.15%

Mr. Jeffrey H. (Jeff) Burbank

Lead Independent Director

53.80K

+13.32%

Dr. Marshall S. Stanton, M.D.

Senior Vice President, Clinical Research and Chief Medical Officer

48.71K

--

Mr. Matthew A. (Matt) Getz

Vice President - Human Resources

34.12K

-21.64%

名稱

名稱/職務

職務

持股

持股變動

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

--

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

--

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer

121.36K

+10.09%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Aortic stent grafts

39.84M

35.27%

On X

25.57M

22.64%

Preservation Services

25.53M

22.60%

Bio Glue

19.29M

17.07%

Surgical sealants

19.29M

17.07%

Other

2.74M

2.43%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Aortic stent grafts

39.84M

35.27%

On X

25.57M

22.64%

Preservation Services

25.53M

22.60%

Bio Glue

19.29M

17.07%

Surgical sealants

19.29M

17.07%

Other

2.74M

2.43%

股東統計

更新時間: 8月17日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.75%

Macquarie Investment Management

6.27%

Perceptive Advisors LLC

5.92%

The Vanguard Group, Inc.

5.91%

Fidelity Management & Research Company LLC

4.66%

其他

65.50%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.75%

Macquarie Investment Management

6.27%

Perceptive Advisors LLC

5.92%

The Vanguard Group, Inc.

5.91%

Fidelity Management & Research Company LLC

4.66%

其他

65.50%

股東類型

持股股東

佔比

Investment Advisor

50.49%

Investment Advisor/Hedge Fund

28.14%

Private Equity

5.92%

Individual Investor

4.71%

Hedge Fund

2.80%

Research Firm

1.29%

Pension Fund

0.94%

Bank and Trust

0.38%

Venture Capital

0.11%

其他

5.23%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

392

42.59M

90.27%

-124.80K

2025Q2

391

44.35M

103.59%

+1.98M

2025Q1

402

44.36M

103.89%

+1.66M

2024Q4

380

41.09M

97.75%

+880.04K

2024Q3

367

38.98M

93.02%

-790.24K

2024Q2

349

38.52M

92.17%

-784.32K

2024Q1

347

38.26M

91.68%

-2.02M

2023Q4

342

37.08M

90.20%

-1.57M

2023Q3

339

37.01M

90.02%

-1.95M

2023Q2

331

37.22M

87.77%

-1.77M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.54M

11.75%

-205.09K

-3.57%

Jun 30, 2025

Macquarie Investment Management

2.96M

6.27%

+52.54K

+1.81%

Jun 30, 2025

Perceptive Advisors LLC

2.79M

5.92%

--

Jun 30, 2025

The Vanguard Group, Inc.

2.79M

5.91%

+16.34K

+0.59%

Jun 30, 2025

Fidelity Management & Research Company LLC

2.20M

4.66%

-584.24K

-21.00%

Jun 30, 2025

Morgan Stanley Smith Barney LLC

1.93M

4.09%

-9.84K

-0.51%

Jun 30, 2025

Juniper Investment Company, LLC

1.86M

3.95%

-229.50K

-10.96%

Aug 08, 2025

Wellington Management Company, LLP

1.71M

3.63%

-13.99K

-0.81%

Jun 30, 2025

State Street Investment Management (US)

1.51M

3.21%

-17.10K

-1.12%

Jun 30, 2025

Fred Alger Management, LLC

1.35M

2.86%

+1.23M

+1018.31%

Jun 30, 2025

持股ETF



更新時間: 11月2日週日

機構名稱

佔比

AAM Sawgrass US Small Cap Quality Growth ETF

3.92%

Unusual Whales Subversive Democratic Trading ETF

3.39%

ROBO Global Healthcare Technology & Innovation ETF

1.73%

SPDR S&P Health Care Equipment ETF

1.49%

Invesco S&P SmallCap Health Care ETF

1.12%

Invesco Dorsey Wright Healthcare Momentum ETF

0.77%

First Trust Small Cap Growth AlphaDEX Fund

0.68%

Invesco S&P SmallCap 600 Pure Growth ETF

0.61%

Invesco Dorsey Wright SmallCap Momentum ETF

0.39%

iShares Micro-Cap ETF

0.34%

AAM Sawgrass US Small Cap Quality Growth ETF

佔比3.92%

Unusual Whales Subversive Democratic Trading ETF

佔比3.39%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.73%

SPDR S&P Health Care Equipment ETF

佔比1.49%

Invesco S&P SmallCap Health Care ETF

佔比1.12%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比0.77%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.68%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比0.61%

Invesco Dorsey Wright SmallCap Momentum ETF

佔比0.39%

iShares Micro-Cap ETF

佔比0.34%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據